You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 4, April 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Critique
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Surgical Physiology, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Polyadenosine Diphosphate–Ribose Polymerase Inhibition Modulates Skeletal Muscle Injury Following Ischemia Reperfusion—Invited Critique

Alden H. Harken, MD

Arch Surg. 2005;140:352.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

If you are one of those surgeons who believes that Darwin was correct, then you must also trust the constructive fortitude of an enzyme that has survived millennia of evolutionary hurdles. It must be doing something good. And the therapeutic arrogance of selectively inhibiting this enzymatic hall-of-famer should be dangerous—like challenging the pope on scripture. But, in this issue of the ARCHIVES, this is exactly what Hua et al have done.

Polyadenosine diphosphate–ribose polymerase is a DNA repair enzyme that is concentrated in cellular royalty (like heart, brain, and skeletal muscle), while PARP is essentially absent in cellular foot soldiers (like white cells). The body is not a democracy. Polyadenosine diphosphate–ribose polymerase requires energy to accomplish its repair work; so, it makes sense that we invest in the nuclear repair of terminally differentiated cells rather than squandering remorse on a bunch of granulocytes that . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Polyadenosine Diphosphate–Ribose Polymerase Inhibition Modulates Skeletal Muscle Injury Following Ischemia Reperfusion
Hong T. Hua, Hassan Albadawi, Fateh Entabi, Mark Conrad, Michael C. Stoner, Bryan T. Meriam, Ramses Sroufe, Stuart Houser, Glenn M. LaMuraglia, and Michael T. Watkins
Arch Surg. 2005;140(4):344-351.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.